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MAPPING OF A Leishmania major GENE/LOCUS THAT CONFERS PENTAMIDINE RESISTANCE BY
DELETION AND INSERTION OF TRANSPOSABLE ELEMENT
Adriano C. COELHO(1), Luiz R. O. TOSI(2) & Paulo C. COTRIM(1)
SUMMARY
Pentamidine (PEN) is an alternative compound to treat antimony-resistant leishmaniasis patients, which cellular target remains
unclear. One approach to the identification of prospective targets is to identify genes able to mediate PEN resistance following
overexpression. Starting from a genomic library of transfected parasites bearing a multicopy episomal cosmid vector containing wild-
type Leishmania major DNA, we isolated one locus capable to render PEN resistance to wild type cells after DNA transfection. In
order to map this Leishmania locus, cosmid insert was deleted by two successive sets of partial digestion with restriction enzymes,
followed by transfection into wild type cells, overexpression, induction and functional tests in the presence of PEN. To determine the
Leishmania gene related to PEN resistance, nucleotide sequencing experiments were done through insertion of the transposon Mariner
element of Drosophila melanogaster (mosK) into the deleted insert to work as primer island. Using general molecular techniques, we
described here this method that permits a quickly identification of a functional gene facilitating nucleotide sequence experiments
from large DNA fragments. Followed experiments revealed the presence of a P-Glycoprotein gene in this locus which role in Leishmania
metabolism has now been analyzed.
KEYWORDS: Leishmania major; Pentamidine; Drug resistance; Gene transfection; Overexpression; Gene mapping; Transposable
element.
INTRODUCTION
Leishmania is a flagellated protozoan and the causative agent of
leishmaniasis, an human infection that can develop as cutaneous,
mucocutaneous, or visceral lesions according to the mononuclear
phagocyte system infected, parasite species or host susceptibility2,12.
Despite recent developments in the chemotherapy for leishmaniasis6,
effective drug treatment remains difficult because of the many
combinations of syndromes, the resistance of Leishmania species and
the lack of adequate clinical trials. Antimony, the most effective agent to
treat the disease is difficult to administer, present potential toxic effects
and are considered expensive for large scale field regiments.
Few other antileishmanial drugs have been as extensively used as
antimonials for treatment of leishmaniasis. Amphotericin B and
Pentamidine (PEN) have generally been chosen as parenteral alternatives
for human cases of poor response to the antimonial regimen. In spite of
their toxic renal effects and the little knowledge of their mode of action
in the parasite, these two agents are now being used with the benefit of
new formulations or dosage regimens12,18.
A better understanding of the mode of action of these agents would
bring new insights into the antileishmanial chemotherapy. From this
perspective, the identification of parasite genomic loci involved in the
development of resistance to these compounds might be of great value.
Such approach is possible through the use of molecular techniques such
as gene transfection, which employs specific shuttle vectors capable of
replication within the parasite, as well as in bacteria. For instance, the
vector cLHYG accepts up to 40 kb inserts of Leishmania genomic DNA
and allows autonomous replication of molecules at a high copy
number9,15,20. In previous work we demonstrated that resistance-related
genes carried by cLHYG can be overexpressed under drug pressure,
yielding specific drug resistance phenotypes in L. major Friedlin A1
strain (LmFA1)5.
Here we describe the use of this overexpression/selection approach
in the presence of PEN, and the mapping of isolated inserts aiming at
functional gene identification.
MATERIAL AND METHODS
Parasite strains, cultures and drugs: Leishmania major strain
Friedlin A1 (LmFA1) is a clonal avirulent line derived from the Friedlin
V1 line (MHOM/IL/80/ Friedlin) after multiple passages in vitro7. Cells
were grown in M199 media11, transfected by electroporation and plated
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on M199 semisolid media5,14, containing Pentamidine (PEN), obtained
from Sigma Chemical Company (St. Louis, MO). For transfections of
cosmids into Leishmania, plates contained 40 µg/ml of hygromycin B
(HYG) were used for selection of transfected lines. To identify cosmid-
bearing lines exhibiting PEN resistance, 106 wild type or cosmid-library
transfected cells were plated on 100 mm M199 plates, containing
increasing concentrations of the selective drug of interest. Macroscopic
colonies were counted after 10-15 days of incubation, and recovered
into M199 medium holding appropriate concentrations of selective drug.
Cosmid libraries and transfection: A library containing 30-40 kb
inserts of Friedlin V1 genomic DNA were constructed into the E. coli -
Leishmania cLHYG shuttle vector as described20. Maxi preparation of
cosmid library DNA was prepared by SDS/alkali lyses plus PEG
precipitation and sterile DNAs were transfected into Friedlin A1 lines
by electroporation, using 14-40 µg DNA per independent transfection
and plating on M199 semi-solid media containing 40 µg/ml HYG5,9,14,20.
Analysis of PEN resistance: PEN resistance of cosmid transfected
cells were performed after DNA overexpression by successive passages
in increasing concentrations of HYG up to 500 µg/ml5. Parasite numbers
were determined using a Coulter Counter (model ZBI) after 2-3 days of
incubation at 26 oC. The inhibition concentration for 50% inhibition
(IC
50
) was defined as that drug concentration which resulted in a 50%
decrease in cell number, measured at the time when control cultures
lacking drug had reached late log phase (typically less than 107/ml)11.
Experiment variations occurring during the tests were controlled by
statistical tests for drug resistance utilized the parameter of fold resistance,





 measured in the same experiment, over (n) independent
experiments.
Molecular techniques: Cosmid DNA was recovered from a liquid
culture with 107 Leishmania cells by an alkaline-SDS lyses plus PEG
precipitation, as described9,10,20. DNA was then transformed in E. coli
(DH5-α strain) and isolated from these cells by SDS/alkali-phenol
extraction and ethanol precipitation. Cosmid DNAs were first mapped
by total digestion with restriction enzymes that have no sites within
cLHYG vector DNA, like HindIII or EcoRV. Deletions were obtained
by partial digestion with 0.1U of HindIII per µg of cosmid DNA, followed
by self-ligation also at partial conditions5.
Nucleotide sequencing strategy and reactions: To determine and
facilitate the nucleotide sequence of the gene related with PEN resistance,
random transposon insertion pools using the mosK mariner transposable
element21. For sequencing reactions, a PCR-based reaction kit was done
with Thermo Sequenase fluorescent labeled primer cycle sequencing kit
with 7-deaza-dGTP (Amersham Pharmacia). DNA sequencing was done
on an ALF Express System (Amersham Pharmacia) automated
sequencing. Nucleotide sequence of DNA inserts containing the mariner
mosK were done using the 5’ and 3’ ends of the transposable element as
primers island with primers directed to these extremities: mosK F 5’-
CCGAGAGAGATGGGAAAAATG-3’ and mosK R 5’-
GGTTGACACTTCACAAGGTC-3’.
Analysis of the sequence was performed using the DNASTAR
software (Madison, WI) and Clone Manager 5TM. We also used for
confirmation and final deduction of the nucleotide sequence of the coding
region, comparison with the data from the Leishmania major Genome
Project at Sanger Center Web Server (www.sanger.ac.uk).
RESULTS
Selection of cosmids containing loci capable of render Leishmania
resistant to PEN was carried out after platting a LmFA1 transfectant
cosmid library with increasing concentrations of PEN (8 to 27 µM). The
number of colonies obtained was compared to that of a control consisting
of parental or cLHYG transfected LmFA1 cells as previously described
(Table I). Control experiments yielded parasite colonies up to 17 µM
PEN but not on higher concentrations. In contrast, LmFA1 cosmid library
transfectants yielded 20 colonies on 23 µM PEN. No colonies were
observed at 27 µM PEN. The cosmid DNAs from 7 colonies showing
differential PEN survival were recovered and analyzed by restriction
digestion. We were able to isolate two cosmid populations (cosPEN1-A
and cosPEN1-B) presenting inserts related to the same locus, which was
named PEN1.
Both cosmid DNAs were transfected back into LmFA1 cells to
confirm their role in PEN resistance, and we could observe that
transfected cells present statistical significant levels of PEN resistance
when compared to LmFA1 wild type cells4.
The PEN1 locus was mapped by restriction analysis. The DNAs of
cosPEN1-A (with an insert of approximately 25 kb), and cosPEN1-B
(with approximately 32 kb) were digested with five restriction enzymes.
The representation of Hind III prototype cosmid maps is shown in Fig.
1A. It is noteworthy that cosPEN1-A is a “natural” deletion of cosPEN1-
B, being entirely contained within the latter. In order to limit the resistance
phenotype locus (Fig. 1A), the smaller cosPEN1-A was used to produce
deletions by partial digestion with HindIII, followed by self-ligation.
The deletion cosPEN1-A ∆HindIII, with an insert of approximately 15
kb, was the only construct that remained able to render PEN resistance
after transfection (Fig. 1A). A second set of deletions using EcoRV partial
digestion was generated from cosPEN1-A ∆HindIII, and none confers
PEN resistance after transfection, suggesting that the gene contains an
internal EcoRV site. A 5 kb SalI fragment from cosPEN1-A ∆Hind III
DNA was subcloned into the shuttle vector pSNBR (Fig. 1A)3. The
resulting construct was named pSNBR/5 kb SalI and did not confer PEN
resistance after transfection into parental LmFA1 cells4.
Table 1
Differential recovery of colonies from cosmid transfectant library and parental
cells (LmFA1) after plating on the indicated PEN concentrations
PEN LmFA1 Cosmid library
concentration cells transfectants
27 µM 0 0
23 µM 0 20
17 µM 10 312
13 µM 200 800
12 µM 500 1000
8 µM 500 > 1000
No PEN > 1000 > 1000
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Primer island sequencing was used to characterize the construct
pSNBR/5 kb SalI. The mariner mosK in vitro transposition system was
used to generate random transposon insertion into the target DNA21.
The transposable element used (mosK) carries the Tn903 kanamycin
resistance gene and allows the selection of insertion events following
transformation into E. coli. Initially, mosK insertions were mapped by
HindIII restriction analysis in order to determine the position of the
transposon insertions along the 5 kb plasmid DNA. The presence of two
HindIII sites within the target DNA and one HindIII site within the
transposable element allowed the discrimination between insertion events
that occurred into the cloned fragment and those in the vector backbone
DNA (Fig. 1B).
Specific primers located at the 5’- and 3’-ends of the transposon
were used in the sequencing of insertion events (Fig. 1B). The sequence
generated from mosK insertions was assembled into a fragment of 4,787
bp corresponding to the total DNA insert of the construct pSNBR/5
kbSalI (GenBank TM accession number AY251609). The 5’-end of the
insert contains an open reading frame (ORF) of 3,696 nucleotides, which
codes for a 1,232 amino acids (Fig. 1B), and was named Pentamidine
Resistance Protien-1 (PRP1)4.
DISCUSSION
Southern blotting analysis revealed that the PEN1 locus is clearly
distinct from those loci previously identified (data not shown), which
are involved in the LmFA1 resistance to antifolates, nucleosides and
sterol biosynthesis inhibitors5. Comparison of amino acid sequences in
GenBankTM through BLAST analysis1 revealed a significant identity with
proteins belonging to the ABC (ATP-Binding Cassette) transporters
superfamily. In many organisms these proteins are involved in the
transport of a variety of compounds through biological membranes13.
The ABC transporters superfamily includes the P-glycoprotein (PGP)
described in L. major and in other Leishmania species such as L.
tarentolae and L. tropica, as well as in other trypanosomatids such as
Trypanosoma cruzi3,8,16,19. The nucleotide identity between PGPs of these
organisms and the PRP1 described here varies from 30 to 40%4. The
comparative analysis also suggested that the predicted gene is not entirely
contained within pSNBR/5 kb SalI plasmid insert due to a missing 5’
portion. All PGPs from other trypanosomatids are coded by ORFs that
are larger than the 3,696 bp found for PRP1. This confirms our
observation that the pSNBR/5 kb SalI construct was not able to confer
PEN resistance to LmFA1 cells after transfection4.
The ABC transporter PGPA renders Leishmania resistant to heavy
metals (arsenite and antimonials). Subcellular localization of PGPA in
Leishmania revealed that the protein is present in intracellular
membranes, suggesting that PGPA confers resistance to arsenite and
antimonials by sequestration of metals into vesicles that could be
exocytosed17. The elucidation of the role of the PRP1 in PEN sensitivity
and/or resistance in Leishmania will not only contribute to the study of
the ability of this organism to evade chemotherapy, but also to the design
of effective treatments.
With the conclusion of the Leishmania genome sequencing project
in a near future, the use of this new methodology for mapping and
interrupting Leishmania gene/loci, can contribute enormously for gene
identification as a practical tool for this new functional genomic era.
RESUMO
Mapeamento de um gene de Leishmania major que confere
resistência a pentamidina por deleção e inserção de elementos
transposicionais
A Pentamidina (PEN) é um composto alternativo para o tratamento
de pacientes com leishmaniose que apresentam resistência ao antimônio,
cujo alvo celular continua incerto. Uma abordagem para se identificar
prováveis alvos seria a identificação e super-expressão de genes capazes
de mediar resistência a PEN. A partir de uma genoteca construída com o
DNA de Leishmania major em um vetor - cosmídio que se desenvolve
tanto em bactérias como nas células do parasita, isolamos um locus que
após transfecção é capaz de produzir resistência a PEN às células do
parasita. Almejando o mapeamento desse locus de leishmania, o inserto
clonado nesse cosmídio foi deletado através de duas digestões parciais
sucessivas com enzimas de restrição, seguida de transfecção em células
selvagens, super-expressão gênica, indução e testes funcionais na
presença de PEN. Para determinar o gene de Leishmania relacionado
com a resistência a PEN, o seqüenciamento de nucleotídeos foi executado
após inserção de elementos transposicionais de Drosophila melanogaster
Fig. 1 - (A) Linear representation of the two related cosmids and the
correspondent deletion that confer PEN resistance after transfection (+).
H, Hind III; E, Eco RV. (B) Representation of the different insertions of
mosK elements into the pSNBR/5 Kb SalI insert. Vertical rectangles
correspond the location of each mosK elements. Arrows indicate the
sequenced region starting from each transposon or from the plasmid.
The positions of the base pairs are indicated. The large arrow indicates
the open reading frame of 3,696 nucleotides (PRP1) contained in this
insert. H, HindIII. E, EcoRV.
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no interior do inserto deletado para atuar como ‘ilhas de iniciadores’.
Descrevemos aqui o mapeamento desse locus, após a inserção
transposicional, que além de facilitar o seqüenciamento de nucleotídeos
de grandes fragmentos de DNA, permite uma rápida identificação do
gene relacionado com esse fenótipo. Experimentos posteriores revelaram
neste locus a presença do gene de uma Glicoproteína-P de membrana,
cujo papel no metabolismo na Leishmania está sendo analisado.
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